×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
COYA – coya therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
COYA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/24
08:00 am
coya
ReAlta Life Sciences Appoints Howard Berman, Ph.D., as CEO and Kia Motesharei, Ph.D., as President and COO
Medium
Report
ReAlta Life Sciences Appoints Howard Berman, Ph.D., as CEO and Kia Motesharei, Ph.D., as President and COO
3/23
08:04 am
coya
Coya Therapeutics (COYA) had its "buy" rating reaffirmed by HC Wainwright. They now have a $18.00 price target on the stock.
Low
Report
Coya Therapeutics (COYA) had its "buy" rating reaffirmed by HC Wainwright. They now have a $18.00 price target on the stock.
3/21
01:31 am
coya
Coya Therapeutics (COYA) was downgraded by Wall Street Zen from "hold
Low
Report
Coya Therapeutics (COYA) was downgraded by Wall Street Zen from "hold
3/18
08:00 am
coya
Coya Therapeutics Announces Publication Demonstrating Regulatory T-Cell Dysfunction and Systemic Inflammation in Frontotemporal Dementia, Supporting Mechanistic Rationale for COYA 302 Immune-Restoring Therapy
Low
Report
Coya Therapeutics Announces Publication Demonstrating Regulatory T-Cell Dysfunction and Systemic Inflammation in Frontotemporal Dementia, Supporting Mechanistic Rationale for COYA 302 Immune-Restoring Therapy
3/16
03:21 pm
coya
Coya Therapeutics (COYA) had its "buy" rating reaffirmed by Chardan Capital. They now have a $14.00 price target on the stock.
Low
Report
Coya Therapeutics (COYA) had its "buy" rating reaffirmed by Chardan Capital. They now have a $14.00 price target on the stock.
3/16
03:21 pm
coya
Coya Therapeutics (COYA) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $15.00 price target on the stock.
Low
Report
Coya Therapeutics (COYA) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $15.00 price target on the stock.
3/16
08:00 am
coya
Coya Therapeutics Provides a Corporate Update and Reports Fiscal 2025 Financial Results
Neutral
Report
Coya Therapeutics Provides a Corporate Update and Reports Fiscal 2025 Financial Results
2/18
08:13 am
coya
Coya Therapeutics (NASDAQ:COYA) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $15.00 price target on the stock.
Medium
Report
Coya Therapeutics (NASDAQ:COYA) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $15.00 price target on the stock.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/23
06:03 am
coya
Form EFFECT Coya Therapeutics, Inc.
Low
Report
Form EFFECT Coya Therapeutics, Inc.
3/20
04:32 pm
coya
Form 424B3 Coya Therapeutics, Inc.
Low
Report
Form 424B3 Coya Therapeutics, Inc.
3/16
09:21 am
coya
Form S-3 Coya Therapeutics, Inc.
Low
Report
Form S-3 Coya Therapeutics, Inc.
3/16
08:12 am
coya
Form 10-K Coya Therapeutics, Inc. For: Dec 31
Low
Report
Form 10-K Coya Therapeutics, Inc. For: Dec 31
3/16
08:08 am
coya
Form 8-K Coya Therapeutics, Inc. For: Mar 16
Low
Report
Form 8-K Coya Therapeutics, Inc. For: Mar 16
3/12
02:53 pm
coya
Form SCHEDULE 13G Coya Therapeutics, Inc. Filed by: Dr. Reddy's Laboratories, Inc.
Low
Report
Form SCHEDULE 13G Coya Therapeutics, Inc. Filed by: Dr. Reddy's Laboratories, Inc.
1/30
01:28 pm
coya
Form SCHEDULE 13G/A Coya Therapeutics, Inc. Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A Coya Therapeutics, Inc. Filed by: VANGUARD GROUP INC
1/30
08:07 am
coya
Form 8-K Coya Therapeutics, Inc. For: Jan 29
Low
Report
Form 8-K Coya Therapeutics, Inc. For: Jan 29
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: